Onc Now: A Career at the Cutting Edge of Nuclear Medicine

Nuclear medicine has undergone extraordinary transformation over the past decades, and it continues to redefine how cancer is diagnosed and treated. In this episode, Ken Herrmann reflects on his journey into nuclear medicine, the rapid evolution from PET to PET-CT, and the rise of theranostics. He discusses the balance between innovation and evidence, the growing role of multidisciplinary cancer care, and what lies ahead for the field, including the potential impact of AI. This is a forward-looking conversation for clinicians and researchers at every stage of their career. Timestamps:  00:00 – Introduction 01:07 – His journey into nuclear medicine 02:45 – Impact of nuclear medicine 03:49 – The evolution of his research 05:22 – Theranostics 06:35 – What is the next breakthrough? 08:20 – Balancing innovation with evidence-based practice 09:45 – Multidisciplinary cancer care 11:30 – Biggest challenges in nuclear medicine 13:42 – Future of nuclear medicine 14:58 – Advice to early-career clinicians 16:00 – The potential of AI 17:57 – Three magic wishes for healthcare